The study of individual cells and cellular networks can greatly benefit from the capabilities of microfabricated devices for the stimulation and the recording of electrical cellular events. In this contribution, we describe the development of a device, which combines capabilities for both electrical and pharmacological cell stimulation, and the subsequent recording of electrical cellular activity. The device combines the unique advantages of integrated circuitry (CMOS technology) for signal processing and microfluidics for drug delivery. Both techniques are ideally suited to study electrogenic mammalian cells, because feature sizes are of the same order as the cell diameter, ∼ 50 μm. Despite these attractive features, we observe a size mismatch between microfluidic devices, with bulky fluidic connections to the outside world, and highly miniaturized CMOS chips. To overcome this problem, we developed a microfluidic flow cell that accommodates a small CMOS chip. We simulated the performances of a flow cell based on a 3-D microfluidic system, and then fabricated the device to experimentally verify the nutrient delivery and localized drug delivery performance. The flow-cell has a constant nutrient flow, and six drug inlets that can individually deliver a drug to the cells. The experimental analysis of the nutrient and drug flow mass transfer properties in the flowcell are in good agreement with our V. Linder · T. Kraus · N. F. de Rooij ( ) SAMLAB,
Introduction
Merging the complementary capabilities of electronic chips and microfluidics will greatly benefit the field of cell biology. On one hand, electronic chips provide high density arrays of transducers for electrical recording and stimulation, and, on the other hand, microfluidics offer automated fluid handling capabilities and tools for the delivery of small, precise quantities of chemicals. Both techniques have feature sizes in the micrometer scale, and are ideally suited to study cell-based systems, such as mammalian cells which typically have a diameter of 10-50 μm. By combining these techniques, the response of cellular electrically activity to chemical and electrical stimulation cues can be thoroughly investigated.
Microelectrode arrays (MEA) are very useful research tools for studying electroactive cells, such as neurons and cardiomyocytes. Since its inception in the early 1970s (Thomas et al., 1972) most devices were based on electrically conductive lines patterned on glass (typically palladium, gold (Gross et al., 1995) or indium tin oxide (Gross et al., 1985) ), and are increasingly becoming a standard tool for research in cell biology (Keefer et al., 2001; Tscherter et al., 2001; Streit et al., 2001; Jimbo and Robinson, 2000) . One current limitation of these microelectrode arrays is the difficulty to connect all the electrodes to the off-chip electronics since each electrode requires a dedicated interconnect to the outside world. The array size is therefore limited by the available space on the perimeter of the chip that can be used for interconnects. Moreover, using off-chip electronics for signal processing, the electrical signal will be deleteriously affected by noise contributions occurring during the transfer of the signal from the MEA to the external filtering and amplifying electronics. These limitations highlight to the need for an electronic chip with both (i) high density arrays of sensing electrodes, and (ii) on-chip electronics for signal processing. The use of CMOS (complementary metal oxide semiconductor) technology fulfills these technical requirements (Bai and Wise, 2001; DeBusschere and Kovacs, 2001; Eversmann et al., 2004) .
Microfluidic systems have become very popular for many bioassays. Two attractive features of microfluidics are especially useful for cellular assays: (i) the possibility to automate nutrient delivery, (Tourovskaia et al., 2005; Hung et al., 2004) and (ii) the capability of directing minute quantities of liquid to the cells with high precision (Kaji et al., 2003; Takayama et al., 2003; Matsubara et al., 2004) . These microfluidic devices need millimeter-scale fluidic connections and/or reservoirs of reagents to ensure the operation of the chip. As a result, microfluidic chips typically have micrometer-sized channels and chambers, but generally cover areas of several square centimeters to allow sufficient space for the connections to the outside world.
The combination of CMOS technology and microfluidics will result in a powerful tool, however their relative sizes are mismatched: CMOS chips are cost efficient only if their area is kept to minimum (several square millimeters), while microfluidic systems require areas much larger than that of CMOS. For microfluidic devices that carry out complex tasks (i.e., localized drug delivery), the area requirements increase further because of the large number of necessary fluidic connections to perform these complex tasks. Quake et al. have, for example, integrated several thousand nL-scale-reactors on a single microfluidic chip that had a size between 20 and 30 cm 2 where each reactor measured several mm 2 . This is still many orders of magnitude larger in size than CMOS chips where μm-sized functionalities can be integrated (Unger et al., 2000; Liu et al., 2003) .
In this contribution, we present a microfluidic device that can accommodate a diced CMOS MEA. The flow cell covers an area large enough for simple fluidic connections to the outside world, with a cavity at the core of the device for accomodating a CMOS chip. Using a 3-D channel layout, we performed simple tasks such as nutrient dispensing, and more complex tasks such as drug assays. We modeled the 
